REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy

Abstract Sterile inflammation resulting in an altered immune response is a key determinant of renal injury in diabetic nephropathy (DN). In this investigation, we evaluated the hypothesis that hyperglycemic conditions augment the pro-inflammatory immune response in the kidney by promoting podocyte-s...

Full description

Saved in:
Bibliographic Details
Main Authors: Siddharth Sunilkumar, Sandeep M. Subrahmanian, Esma I. Yerlikaya, Allyson L. Toro, Edward W. Harhaj, Scot R. Kimball, Michael D. Dennis
Format: Article
Language:English
Published: Nature Publishing Group 2025-02-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-025-07396-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861590671228928
author Siddharth Sunilkumar
Sandeep M. Subrahmanian
Esma I. Yerlikaya
Allyson L. Toro
Edward W. Harhaj
Scot R. Kimball
Michael D. Dennis
author_facet Siddharth Sunilkumar
Sandeep M. Subrahmanian
Esma I. Yerlikaya
Allyson L. Toro
Edward W. Harhaj
Scot R. Kimball
Michael D. Dennis
author_sort Siddharth Sunilkumar
collection DOAJ
description Abstract Sterile inflammation resulting in an altered immune response is a key determinant of renal injury in diabetic nephropathy (DN). In this investigation, we evaluated the hypothesis that hyperglycemic conditions augment the pro-inflammatory immune response in the kidney by promoting podocyte-specific expression of the stress response protein regulated in development and DNA damage response 1 (REDD1). In support of the hypothesis, streptozotocin (STZ)-induced diabetes increased REDD1 protein abundance in the kidney concomitant with renal immune cell infiltration. In diabetic mice, administration of the SGLT2 inhibitor dapagliflozin was followed by reductions in blood glucose concentration, renal REDD1 protein abundance, and immune cell infiltration. In contrast with diabetic REDD1+/+ mice, diabetic REDD1−/− mice did not exhibit albuminuria, increased pro-inflammatory factors, or renal macrophage infiltration. In cultured human podocytes, exposure to hyperglycemic conditions promoted REDD1-dependent activation of NF-κB signaling. REDD1 deletion in podocytes attenuated both the increase in chemokine expression and macrophage chemotaxis under hyperglycemic conditions. Notably, podocyte-specific REDD1 deletion prevented the pro-inflammatory immune cell infiltration in the kidneys of diabetic mice. Furthermore, exposure of podocytes to hyperglycemic conditions promoted REDD1-dependent pyroptotic cell death, evidenced by an NLRP3-mediated increase in caspase-1 activity and LDH release. REDD1 expression in podocytes was also required for an increase in pyroptosis markers in the glomeruli of diabetic mice. The data support that podocyte-specific REDD1 is necessary for chronic NF-κB activation in the context of diabetes and raises the prospect that therapies targeting podocyte-specific REDD1 may be helpful in DN.
format Article
id doaj-art-c1b47edd74ec4df49bcb429a45c85e37
institution Kabale University
issn 2041-4889
language English
publishDate 2025-02-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-c1b47edd74ec4df49bcb429a45c85e372025-02-09T12:56:42ZengNature Publishing GroupCell Death and Disease2041-48892025-02-0116111110.1038/s41419-025-07396-4REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathySiddharth Sunilkumar0Sandeep M. Subrahmanian1Esma I. Yerlikaya2Allyson L. Toro3Edward W. Harhaj4Scot R. Kimball5Michael D. Dennis6Department of Cellular and Molecular Physiology, Penn State College of MedicineDepartment of Cellular and Molecular Physiology, Penn State College of MedicineDepartment of Cellular and Molecular Physiology, Penn State College of MedicineDepartment of Cellular and Molecular Physiology, Penn State College of MedicineDepartment of Microbiology and Immunology, Penn State College of MedicineDepartment of Cellular and Molecular Physiology, Penn State College of MedicineDepartment of Cellular and Molecular Physiology, Penn State College of MedicineAbstract Sterile inflammation resulting in an altered immune response is a key determinant of renal injury in diabetic nephropathy (DN). In this investigation, we evaluated the hypothesis that hyperglycemic conditions augment the pro-inflammatory immune response in the kidney by promoting podocyte-specific expression of the stress response protein regulated in development and DNA damage response 1 (REDD1). In support of the hypothesis, streptozotocin (STZ)-induced diabetes increased REDD1 protein abundance in the kidney concomitant with renal immune cell infiltration. In diabetic mice, administration of the SGLT2 inhibitor dapagliflozin was followed by reductions in blood glucose concentration, renal REDD1 protein abundance, and immune cell infiltration. In contrast with diabetic REDD1+/+ mice, diabetic REDD1−/− mice did not exhibit albuminuria, increased pro-inflammatory factors, or renal macrophage infiltration. In cultured human podocytes, exposure to hyperglycemic conditions promoted REDD1-dependent activation of NF-κB signaling. REDD1 deletion in podocytes attenuated both the increase in chemokine expression and macrophage chemotaxis under hyperglycemic conditions. Notably, podocyte-specific REDD1 deletion prevented the pro-inflammatory immune cell infiltration in the kidneys of diabetic mice. Furthermore, exposure of podocytes to hyperglycemic conditions promoted REDD1-dependent pyroptotic cell death, evidenced by an NLRP3-mediated increase in caspase-1 activity and LDH release. REDD1 expression in podocytes was also required for an increase in pyroptosis markers in the glomeruli of diabetic mice. The data support that podocyte-specific REDD1 is necessary for chronic NF-κB activation in the context of diabetes and raises the prospect that therapies targeting podocyte-specific REDD1 may be helpful in DN.https://doi.org/10.1038/s41419-025-07396-4
spellingShingle Siddharth Sunilkumar
Sandeep M. Subrahmanian
Esma I. Yerlikaya
Allyson L. Toro
Edward W. Harhaj
Scot R. Kimball
Michael D. Dennis
REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy
Cell Death and Disease
title REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy
title_full REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy
title_fullStr REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy
title_full_unstemmed REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy
title_short REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy
title_sort redd1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin induced diabetic nephropathy
url https://doi.org/10.1038/s41419-025-07396-4
work_keys_str_mv AT siddharthsunilkumar redd1expressioninpodocytesfacilitatesrenalinflammationandpyroptosisinstreptozotocininduceddiabeticnephropathy
AT sandeepmsubrahmanian redd1expressioninpodocytesfacilitatesrenalinflammationandpyroptosisinstreptozotocininduceddiabeticnephropathy
AT esmaiyerlikaya redd1expressioninpodocytesfacilitatesrenalinflammationandpyroptosisinstreptozotocininduceddiabeticnephropathy
AT allysonltoro redd1expressioninpodocytesfacilitatesrenalinflammationandpyroptosisinstreptozotocininduceddiabeticnephropathy
AT edwardwharhaj redd1expressioninpodocytesfacilitatesrenalinflammationandpyroptosisinstreptozotocininduceddiabeticnephropathy
AT scotrkimball redd1expressioninpodocytesfacilitatesrenalinflammationandpyroptosisinstreptozotocininduceddiabeticnephropathy
AT michaelddennis redd1expressioninpodocytesfacilitatesrenalinflammationandpyroptosisinstreptozotocininduceddiabeticnephropathy